User:Jiaming Zhuang/Sandbox 2: Difference between revisions

Revision as of 02:02, 21 December 2012 view source Jiaming Zhuang (talk \| contribs) 37 edits No edit summary ← Older edit		Revision as of 02:28, 21 December 2012 view source Jiaming Zhuang (talk \| contribs) 37 edits No edit summary Newer edit →
Line 1:		Line 1:
	<Structure load='1gkc' size='400' frame='true' align='right' caption='MMP9' scene='Insert optional scene name here' />		<Structure load='1gkc' size='400' frame='true' align='right' caption='MMP9' scene='Insert optional scene name here' />

	MMP9 is a member of ''' matrix metalloproteinases''' (MMPs) which are zinc-dependent endopeptidases. It has been found to associate with many types of cancers and investigated as a potential drug target. Various of <scene name='User:Jiaming_Zhuang/Sandbox_2/Ligand/1'>inhibitors</scene> have been designed to bind to the [[catalytic domain]] and inhibit the activity of MMP9.		MMP9 is a member of ''' matrix metalloproteinases''' (MMPs) which are zinc-dependent endopeptidases. It has been found to associate with many types of cancers and investigated as a potential drug target. Various of <scene name='User:Jiaming_Zhuang/Sandbox_2/Ligand/1'>inhibitors</scene> have been designed to bind to the <scene name='User:Jiaming_Zhuang/Sandbox_2/Domain/1'>catalytic domain</scene> and inhibit the activity of MMP9.

Navigation menu